Xeloda as first-line therapy of metastatic colorectal cancer-our experience

Xeloda as first-line therapy of metastatic colorectal cancer-our experience

BACKGROUND: Results of phase III clinical studies comparing efficacy of Xeloda vs. standard 5-FU/FA protocols as first line therapy of metastatic colorectal carcinoma (MCRC), have shown better efficacy of Xeloda, with less toxic adverse effects, apart from handfoot syndrome. METHODS: From January 20...

Full description

Bibliographic Details
Main Authors: Kovčin Vladimir, Ješić Rada, Krivokapić Zoran V., Andrić Zoran, Pavlović Aleksandra
Format: Article
Language:English
Published: Institute of Oncology, Sremska Kamenica, Serbia 2002-01-01
Series:Archive of Oncology
Subjects:
Colorectal neoplasms
antimetabolites
antineoplastic
combined chemotherapy protocols
neoplasm metastasis
treatment outcome
Online Access:http://www.doiserbia.nb.rs/img/doi/0354-7310/2002/0354-73100204249K.pdf

Internet

http://www.doiserbia.nb.rs/img/doi/0354-7310/2002/0354-73100204249K.pdf

Similar Items